Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)
Blauvelt, A., Prinz, J.C., Gottlieb, A.B., Kingo, K., Sofen, H., Ruer-Mulard, M., Singh, V., Pathan, R., Papavassilis, C., Cooper, S.
Published in British journal of dermatology (1951) (01.02.2015)
Published in British journal of dermatology (1951) (01.02.2015)
Get full text
Journal Article
Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial
Bissonnette, R., Iversen, L., Sofen, H., Griffiths, C.E.M., Foley, P., Romiti, R., Bachinsky, M., Rottinghaus, S.T., Tan, H., Proulx, J., Valdez, H., Gupta, P., Mallbris, L., Wolk, R.
Published in British journal of dermatology (1951) (01.05.2015)
Published in British journal of dermatology (1951) (01.05.2015)
Get full text
Journal Article
The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study
Bissonnette, R., Maari, C., Forman, S., Bhatia, N., Lee, M., Fowler, J., Tyring, S., Pariser, D., Sofen, H., Dhawan, S., Zook, M., Zammit, D.J., Usansky, H., Denis, L., Rao, N., Song, T., Pavel, A.B., Guttman‐Yassky, E.
Published in British journal of dermatology (1951) (01.10.2019)
Published in British journal of dermatology (1951) (01.10.2019)
Get full text
Journal Article
Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate‐to‐severe psoriasis: a pooled analysis of two randomized controlled trials
Blauvelt, A., Sofen, H., Papp, K., Gooderham, M., Tyring, S., Zhao, Y., Lowry, S., Mendelsohn, A., Parno, J., Reich, K.
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2019)
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2019)
Get full text
Journal Article
Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema
Maurer, M., Sofen, H., Ortiz, B., Kianifard, F., Gabriel, S., Bernstein, J.A.
Published in Journal of the European Academy of Dermatology and Venereology (01.06.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.06.2017)
Get full text
Journal Article
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study
Kimball, A.B., Papp, K.A., Wasfi, Y., Chan, D., Bissonnette, R., Sofen, H., Yeilding, N., Li, S., Szapary, P., Gordon, K.B.
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2013)
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2013)
Get full text
Journal Article
Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1
Rich, P., Bourcier, M., Sofen, H., Fakharzadeh, S., Wasfi, Y., Wang, Y., Kerkmann, U., Ghislain, P.-D., Poulin, Y.
Published in British journal of dermatology (1951) (01.02.2014)
Published in British journal of dermatology (1951) (01.02.2014)
Get full text
Journal Article
Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis
Blauvelt, A., Papp, K.A., Sofen, H., Augustin, M., Yosipovitch, G., Katoh, N., Mrowietz, U., Ohtsuki, M., Poulin, Y., Shrom, D., Burge, R., See, K., Mallbris, L., Gordon, K.B.
Published in Journal of the European Academy of Dermatology and Venereology (01.06.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.06.2017)
Get full text
Journal Article
Three‐year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial
Warren, R. B., Lebwohl, M., Sofen, H., Piguet, V., Augustin, M., Brock, F., C. Arendt, Fierens, F., Blauvelt, A.
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2021)
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2021)
Get full text
Journal Article
Efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study
Van Voorhees, A.S., Stein Gold, L., Lebwohl, M., Strober, B., Sofen, H., Papp, K., Bagel, J., Zhang, Z., Paris, M., Wang, Y.
Published in British journal of dermatology (1951) (01.10.2021)
Published in British journal of dermatology (1951) (01.10.2021)
Get full text
Journal Article
Rapid improvements in health‐related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER‐2 and UNCOVER‐3
Leonardi, C.L., Blauvelt, A., Sofen, H.L., Gooderham, M., Augustin, M., Burge, R., Zhu, B., Reich, K.
Published in Journal of the European Academy of Dermatology and Venereology (01.09.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.09.2017)
Get full text
Journal Article
Noninvasive genomic detection of melanoma
Wachsman, W., Morhenn, V., Palmer, T., Walls, L., Hata, T., Zalla, J., Scheinberg, R., Sofen, H., Mraz, S., Gross, K., Rabinovitz, H., Polsky, D., Chang, S.
Published in British journal of dermatology (1951) (01.04.2011)
Published in British journal of dermatology (1951) (01.04.2011)
Get full text
Journal Article
THU0291 Incidence of serious gastrointestinal events and inflammatory bowel disease among tildrakizumab-treated patients with moderate to severe plaque psoriasis: data from 3 large randomised clinical trials
Gooderham, M., Elewski, B.E., Pariser, D.M., Sofen, H., Mendelsohn, A.M., Cichanowitz, N., Li, Q., La Rosa, C.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
Effect of tofacitinib withdrawal and re‐treatment on patient‐reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis
Griffiths, C.E.M., Vender, R., Sofen, H., Kircik, L., Tan, H., Rottinghaus, S.T., Bachinsky, M., Mallbris, L., Mamolo, C.
Published in Journal of the European Academy of Dermatology and Venereology (01.02.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.02.2017)
Get full text
Journal Article
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from the CLEAR study
Blauvelt, A., Reich, K., Mehlis, S., Vanaclocha, F., Sofen, H., Abramovits, W., Zhao, Y., Gilloteau, I., Davenport, E., Williams, N., Guana, A., Tyring, S.
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2017)
Get full text
Journal Article
Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate‐to‐severe psoriasis patients: 12‐week results from two phase III trials
Paul, C., Guenther, L., Torii, H., Sofen, H., Burge, R., Lin, C.Y., Potts Bleakman, A., Mallbris, L., Poulin, Y.
Published in Journal of the European Academy of Dermatology and Venereology (01.01.2018)
Published in Journal of the European Academy of Dermatology and Venereology (01.01.2018)
Get full text
Journal Article
Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis: Letter to the Editor
Gooderham, M, Elewski, B E, Pariser, D M, Sofen, H, Mendelsohn, A M, Rozzo, S J, Li, Q
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2019)
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2019)
Get full text
Journal Article
ASN002 证明有疗效并可改善AD 炎症
Bissonnette, R., Maari, C., Forman, S., Bhatia, N., Lee, M., Fowler, J., Tyring, S., Pariser, D., Sofen, H., Dhawan, S., Zook, M., Zammit, D.J., Usansky, H., Denis, L., Rao, N., Song, T., Pavel, A.B., Guttman‐Yassky, E.
Published in British journal of dermatology (1951) (01.10.2019)
Published in British journal of dermatology (1951) (01.10.2019)
Get full text
Journal Article
ASN002 demonstrates efficacy and improves inflammation in AD
Bissonnette, R., Maari, C., Forman, S., Bhatia, N., Lee, M., Fowler, J., Tyring, S., Pariser, D., Sofen, H., Dhawan, S., Zook, M., Zammit, D.J., Usansky, H., Denis, L., Rao, N., Song, T., Pavel, A.B., Guttman‐Yassky, E.
Published in British journal of dermatology (1951) (01.10.2019)
Published in British journal of dermatology (1951) (01.10.2019)
Get full text
Journal Article
A reliability study using Network Oriented Research Assistant (NORA®) examining the use of digital photographs in the assessment of psoriasis
Jeong, D., Aralis, H., Bruhn, K.W., Cotliar, J., Craft, N., DeLuca, I.J., Hamidi, R., Nguyen, K., Patel, V.A., Sofen, H., Tan, B.H., David, C.V.
Published in British journal of dermatology (1951) (01.07.2019)
Published in British journal of dermatology (1951) (01.07.2019)
Get full text
Journal Article